1. P528 Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multi-centre, prospective, observational cohort study. (25th January 2019) Authors: Pineton de Chambrun, G; Pariente, B; Seksik, P; Altwegg, R; Vuitton, L; Stefasnescu, C; Nancey, S; Aubourg, A; Serrero, M; Peyrin-Biroulet, L; Filippi, J; Viennot, S; Abitbol, V; Boualit, M; Boureille, A; Moreau, J; Buisson, A; Roblin, X; Nachury, M; Zappa, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P745 Incidence of indeterminate colitis in the EPIMAD registry decreases over the period 1988–2014. (25th January 2019) Authors: Mayer, P; Sarter, H; Fumery, M; Savoye, G; Leroyer, A; Dauchet, L; Gower-Rousseau, C; Pariente, B Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S494 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP25 Targeting endoscopic outcomes through combined pharmacokinetic and pharmacodynamic monitoring of infliximab therapy in patients with Crohn's disease. (25th January 2019) Authors: Dreesen, E; Baert, F; Laharie, D; Bossuyt, P; Bouhnik, Y; Buisson, A; Lambrecht, G; Louis, E; Oldenburg, B; Pariente, B; Pierik, M; van der Woude, C J; D'Haens, G; Vermeire, S; Gils, A Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S016 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P751 Perianal lesions in Crohn's disease: analysis of Epimad registry from 2007 to 2012. (25th January 2019) Authors: Wils, P; Leroyer, A; Fumery, M; Fernandez Nistal, A; Bojic, D; D′Ambrosio, R; Sarter, H; Savoye, G; Gower-Rousseau, C; Pariente, B Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P323 Prognostic factors for long-term adalimumab treatment. (25th January 2019) Authors: Fumery, M; Duveau, N; Perignon, C; Lepeut, G; Lahaye, A; Le Baut, G; Roussillon, C; Yzet, C; Loreau, J; Wils, P; Nachury, M; Pariente, B; Viennot, S Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study. (22nd February 2019) Authors: Pineton de Chambrun, G; Pariente, B; Seksik, P; Altwegg, R; Vuitton, L; Stefasnescu, C; Nancey, S; Aubourg, A; Serrero, M; Peyrin-Biroulet, L; Filippi, J; Viennot, S; Abitbol, V; Boualit, M; Boureille, A; Moreau, J; Buisson, A; Roblin, X; Nachury, M; Zappa, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S616 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OP35 Endoscopic and deep remission at 1 year prevents disease progression in early Crohn's disease: long-term data from CALM. (25th January 2019) Authors: Yzet, C; Ungaro, R; Bossuyt, P; Baert, F; Vanasek, T; D'Haens, G; Joustra, V; Panaccione, R; Novacek, G; Armuzzi, A; Golovchenko, O; Prymak, O; Goldis, A; Travis, S; Hébuterne, X; Ferrante, M; Rogler, G; Fumery, M; Danese, S; Rydzewska, G Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S024 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P741 Fine-scale geographic distribution and ecological studies of Crohn's disease in France (2007–2014). (25th January 2019) Authors: Genin, M; Fumery, M; Occelli, F; Savoye, G; Pariente, B; Dauchet, L; Vignal, C; Body-Malapel, M; Giovannelli, J; Sarter, H; Gower-Rousseau, C; Ficheur, G Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P711 The real-life experience of vedolizumab therapy in the OBSERV-IBD cohort: a 3-year prospective observational multi-centre cohort study. (25th January 2019) Authors: Amiot, A; Serrero, M; Peyrin-Biroulet, L; Filippi, J; Pariente, B; Roblin, X; Buisson, A; Stefanescu, C; Trang-Poisson, C; Altwegg, R; Marteau, P; Vaysse, T; Bourrier, A; Nancey, S; Laharie, D; Allez, M; Savoye, G; Moreau, J; Vuitton, L; Viennot, S Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P413 A simple scoring tool predicts exposure–response relationship, onset of action, response to interval shortening, and surgical risk with vedolizumab therapy for Crohn's disease. (25th January 2019) Authors: Dulai, P S; Amiot, A; Peyrin-Biroulet, L; Singh, S; Serrero, M; Jairath, V; Filippi, J; Pariente, B; Loftus Jr, E V; Roblin, X; Kane, S; Buisson, A; Siegel, C A; Bouhnik, Y; Sandborn, W J; Lasch, K; Rosario, M; Feagan, B G; Bojic, D; Trang-Poisson, C Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗